Predicting Treatment Response in Schizophrenia With Magnetic Resonance Imaging and Polygenic Risk Score

Background: Prior studies have separately demonstrated that magnetic resonance imaging (MRI) and schizophrenia polygenic risk score (PRS) are predictive of antipsychotic medication treatment outcomes in schizophrenia. However, it remains unclear whether MRI combined with PRS can provide superior pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Meng, Hu, Ke, Fan, Lingzhong, Yan, Hao, Li, Peng, Jiang, Tianzi, Liu, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847599/
https://www.ncbi.nlm.nih.gov/pubmed/35186051
http://dx.doi.org/10.3389/fgene.2022.848205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847599/
https://www.ncbi.nlm.nih.gov/pubmed/35186051
http://dx.doi.org/10.3389/fgene.2022.848205

Ejemplares similares